nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—RYR3—diaphragm—lung cancer	0.139	0.943	CbGeAlD
Dantrolene—CYP3A4—Topotecan—lung cancer	0.0528	0.142	CbGbCtD
Dantrolene—CYP3A4—Gefitinib—lung cancer	0.0483	0.13	CbGbCtD
Dantrolene—CYP3A4—Teniposide—lung cancer	0.0468	0.126	CbGbCtD
Dantrolene—CYP3A4—Vinorelbine—lung cancer	0.0372	0.1	CbGbCtD
Dantrolene—CYP3A4—Crizotinib—lung cancer	0.0296	0.0796	CbGbCtD
Dantrolene—CYP3A4—Erlotinib—lung cancer	0.0285	0.0768	CbGbCtD
Dantrolene—CYP3A4—Paclitaxel—lung cancer	0.0261	0.0703	CbGbCtD
Dantrolene—CYP3A4—Irinotecan—lung cancer	0.0258	0.0694	CbGbCtD
Dantrolene—CYP3A4—Vinblastine—lung cancer	0.0229	0.0617	CbGbCtD
Dantrolene—CYP3A4—Etoposide—lung cancer	0.0206	0.0556	CbGbCtD
Dantrolene—CYP3A4—Docetaxel—lung cancer	0.0189	0.0508	CbGbCtD
Dantrolene—CYP3A4—Doxorubicin—lung cancer	0.0141	0.0379	CbGbCtD
Dantrolene—RYR3—lung—lung cancer	0.00842	0.0572	CbGeAlD
Dantrolene—RYR3—Alzheimers Disease—HSD17B10—lung cancer	0.00805	0.0717	CbGpPWpGaD
Dantrolene—RYR3—MFAP5-mediated ovarian cancer cell motility and invasiveness—JUN—lung cancer	0.00547	0.0487	CbGpPWpGaD
Dantrolene—Nitrofurantoin—ABCG2—lung cancer	0.005	0.827	CrCbGaD
Dantrolene—RYR3—Alzheimers Disease—APP—lung cancer	0.00326	0.029	CbGpPWpGaD
Dantrolene—CYP3A4—Felbamate Metabolism—CYP2E1—lung cancer	0.00304	0.0271	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—OXTR—lung cancer	0.00273	0.0243	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—GNG11—lung cancer	0.00263	0.0235	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—GNG11—lung cancer	0.00255	0.0227	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—SFN—lung cancer	0.00251	0.0223	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—SFN—lung cancer	0.00243	0.0216	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—ATF3—lung cancer	0.00238	0.0212	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—ADCY1—lung cancer	0.00237	0.0211	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—ADCY1—lung cancer	0.00229	0.0204	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00208	0.0185	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—OXTR—lung cancer	0.00201	0.0179	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—GNG11—lung cancer	0.00194	0.0173	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—GNG11—lung cancer	0.00188	0.0168	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—SFN—lung cancer	0.00185	0.0165	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—SFN—lung cancer	0.00179	0.016	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—ATF3—lung cancer	0.00175	0.0156	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ADCY1—lung cancer	0.00175	0.0155	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—ADCY1—lung cancer	0.00169	0.0151	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—CASP8—lung cancer	0.00165	0.0147	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00158	0.0141	CbGpPWpGaD
Dantrolene—CYP3A4—Codeine and Morphine Metabolism—ABCC3—lung cancer	0.00154	0.0137	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00154	0.0137	CbGpPWpGaD
Dantrolene—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—lung cancer	0.00145	0.0129	CbGpPWpGaD
Dantrolene—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—lung cancer	0.00136	0.0121	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—CASP3—lung cancer	0.00125	0.0111	CbGpPWpGaD
Dantrolene—RYR3—Stimuli-sensing channels—RAF1—lung cancer	0.0012	0.0107	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00116	0.0104	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—MAPK3—lung cancer	0.001	0.00892	CbGpPWpGaD
Dantrolene—CYP3A4—Xenobiotics—CYP2A7—lung cancer	0.000976	0.00869	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000945	0.00842	CbGpPWpGaD
Dantrolene—CYP3A4—Irinotecan Pathway—UGT1A1—lung cancer	0.000925	0.00824	CbGpPWpGaD
Dantrolene—RYR1—Stimuli-sensing channels—RAF1—lung cancer	0.000883	0.00787	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—GNG11—lung cancer	0.000857	0.00763	CbGpPWpGaD
Dantrolene—CYP3A4—Aflatoxin B1 metabolism—GSTM1—lung cancer	0.000846	0.00754	CbGpPWpGaD
Dantrolene—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	0.000842	0.0075	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—GSTA1—lung cancer	0.000814	0.00725	CbGpPWpGaD
Dantrolene—CYP3A4—Irinotecan Pathway—ABCG2—lung cancer	0.000802	0.00714	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—TP53—lung cancer	0.0008	0.00712	CbGpPWpGaD
Dantrolene—CYP3A4—Codeine and Morphine Metabolism—ABCB1—lung cancer	0.000783	0.00698	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—RAF1—lung cancer	0.000782	0.00696	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000771	0.00686	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000771	0.00686	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—UGT1A1—lung cancer	0.000757	0.00674	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—TF—lung cancer	0.000716	0.00638	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—JUN—lung cancer	0.000706	0.00629	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000697	0.00621	CbGpPWpGaD
Dantrolene—Nitrazepam—CYP2E1—lung cancer	0.000686	0.114	CrCbGaD
Dantrolene—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—lung cancer	0.000678	0.00604	CbGpPWpGaD
Dantrolene—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—lung cancer	0.000656	0.00584	CbGpPWpGaD
Dantrolene—CYP3A4—Tryptophan metabolism—HSD17B10—lung cancer	0.000634	0.00565	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—GNG11—lung cancer	0.000632	0.00563	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—RAF1—lung cancer	0.000576	0.00513	CbGpPWpGaD
Dantrolene—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—lung cancer	0.000576	0.00513	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000568	0.00506	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000568	0.00506	CbGpPWpGaD
Dantrolene—CYP3A4—Xenobiotics—CYP2A6—lung cancer	0.000567	0.00505	CbGpPWpGaD
Dantrolene—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	0.000545	0.00486	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000532	0.00474	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—TF—lung cancer	0.000528	0.0047	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—JUN—lung cancer	0.000521	0.00464	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—NQO1—lung cancer	0.000519	0.00462	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000508	0.00452	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—AVP—lung cancer	0.000497	0.00442	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.000484	0.00431	CbGpPWpGaD
Dantrolene—CYP3A4—Xenobiotics—CYP2E1—lung cancer	0.000482	0.00429	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000481	0.00428	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000478	0.00425	CbGpPWpGaD
Dantrolene—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	0.000464	0.00413	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000443	0.00394	CbGpPWpGaD
Dantrolene—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.000429	0.00382	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL6—lung cancer	0.000427	0.0038	CbGpPWpGaD
Dantrolene—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.000414	0.00369	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000405	0.00361	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.0004	0.00356	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.000397	0.00354	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000389	0.00347	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—APOA1—lung cancer	0.00038	0.00338	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.000377	0.00336	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—AVP—lung cancer	0.000366	0.00326	CbGpPWpGaD
Dantrolene—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.000361	0.00321	CbGpPWpGaD
Dantrolene—Nitrazepam—ABCB1—lung cancer	0.00036	0.0595	CrCbGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000355	0.00316	CbGpPWpGaD
Dantrolene—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.000346	0.00308	CbGpPWpGaD
Dantrolene—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.000333	0.00297	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000329	0.00293	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000321	0.00286	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000315	0.00281	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL6—lung cancer	0.000315	0.0028	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ALB—lung cancer	0.000301	0.00268	CbGpPWpGaD
Dantrolene—Constipation—Irinotecan—lung cancer	0.000296	0.000816	CcSEcCtD
Dantrolene—Pain—Irinotecan—lung cancer	0.000296	0.000816	CcSEcCtD
Dantrolene—Myalgia—Paclitaxel—lung cancer	0.000294	0.000812	CcSEcCtD
Dantrolene—Erythema—Docetaxel—lung cancer	0.000293	0.000808	CcSEcCtD
Dantrolene—Decreased appetite—Gemcitabine—lung cancer	0.000293	0.000808	CcSEcCtD
Dantrolene—Nausea—Topotecan—lung cancer	0.000291	0.000803	CcSEcCtD
Dantrolene—Discomfort—Paclitaxel—lung cancer	0.000291	0.000802	CcSEcCtD
Dantrolene—Fatigue—Gemcitabine—lung cancer	0.000291	0.000801	CcSEcCtD
Dantrolene—Confusional state—Etoposide—lung cancer	0.00029	0.0008	CcSEcCtD
Dantrolene—Pain—Gemcitabine—lung cancer	0.000288	0.000795	CcSEcCtD
Dantrolene—Constipation—Gemcitabine—lung cancer	0.000288	0.000795	CcSEcCtD
Dantrolene—Nausea—Erlotinib—lung cancer	0.000288	0.000795	CcSEcCtD
Dantrolene—Dry mouth—Paclitaxel—lung cancer	0.000288	0.000794	CcSEcCtD
Dantrolene—Anaphylactic shock—Etoposide—lung cancer	0.000288	0.000794	CcSEcCtD
Dantrolene—Diarrhoea—Vinorelbine—lung cancer	0.000287	0.000792	CcSEcCtD
Dantrolene—Dysgeusia—Docetaxel—lung cancer	0.000287	0.000791	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000286	0.000789	CcSEcCtD
Dantrolene—Feeling abnormal—Irinotecan—lung cancer	0.000285	0.000786	CcSEcCtD
Dantrolene—Confusional state—Paclitaxel—lung cancer	0.000285	0.000785	CcSEcCtD
Dantrolene—Back pain—Docetaxel—lung cancer	0.000284	0.000782	CcSEcCtD
Dantrolene—Gastrointestinal pain—Irinotecan—lung cancer	0.000283	0.00078	CcSEcCtD
Dantrolene—Anaphylactic shock—Paclitaxel—lung cancer	0.000282	0.000778	CcSEcCtD
Dantrolene—Thrombocytopenia—Etoposide—lung cancer	0.000282	0.000777	CcSEcCtD
Dantrolene—Tachycardia—Etoposide—lung cancer	0.000281	0.000775	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—APOA1—lung cancer	0.00028	0.00249	CbGpPWpGaD
Dantrolene—Hyperhidrosis—Etoposide—lung cancer	0.000278	0.000767	CcSEcCtD
Dantrolene—Feeling abnormal—Gemcitabine—lung cancer	0.000278	0.000766	CcSEcCtD
Dantrolene—Dizziness—Vinorelbine—lung cancer	0.000278	0.000765	CcSEcCtD
Dantrolene—Thrombocytopenia—Paclitaxel—lung cancer	0.000276	0.000762	CcSEcCtD
Dantrolene—Tachycardia—Paclitaxel—lung cancer	0.000275	0.000759	CcSEcCtD
Dantrolene—Anorexia—Etoposide—lung cancer	0.000274	0.000757	CcSEcCtD
Dantrolene—Abdominal pain—Irinotecan—lung cancer	0.000274	0.000754	CcSEcCtD
Dantrolene—Body temperature increased—Irinotecan—lung cancer	0.000274	0.000754	CcSEcCtD
Dantrolene—Decreased appetite—Cisplatin—lung cancer	0.000273	0.000753	CcSEcCtD
Dantrolene—Hyperhidrosis—Paclitaxel—lung cancer	0.000273	0.000752	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—RAF1—lung cancer	0.000272	0.00242	CbGpPWpGaD
Dantrolene—Anaemia—Docetaxel—lung cancer	0.000271	0.000747	CcSEcCtD
Dantrolene—Drowsiness—Methotrexate—lung cancer	0.00027	0.000745	CcSEcCtD
Dantrolene—Depression—Methotrexate—lung cancer	0.00027	0.000743	CcSEcCtD
Dantrolene—Anorexia—Paclitaxel—lung cancer	0.000269	0.000742	CcSEcCtD
Dantrolene—Pain—Cisplatin—lung cancer	0.000269	0.000741	CcSEcCtD
Dantrolene—Muscular weakness—Doxorubicin—lung cancer	0.000268	0.000739	CcSEcCtD
Dantrolene—Vomiting—Vinorelbine—lung cancer	0.000267	0.000736	CcSEcCtD
Dantrolene—Body temperature increased—Gemcitabine—lung cancer	0.000267	0.000735	CcSEcCtD
Dantrolene—Renal failure—Methotrexate—lung cancer	0.000266	0.000733	CcSEcCtD
Dantrolene—Rash—Vinorelbine—lung cancer	0.000265	0.000729	CcSEcCtD
Dantrolene—Dermatitis—Vinorelbine—lung cancer	0.000264	0.000729	CcSEcCtD
Dantrolene—Headache—Vinorelbine—lung cancer	0.000263	0.000725	CcSEcCtD
Dantrolene—Dysphagia—Doxorubicin—lung cancer	0.000263	0.000724	CcSEcCtD
Dantrolene—Leukopenia—Docetaxel—lung cancer	0.000262	0.000723	CcSEcCtD
Dantrolene—Eosinophilia—Doxorubicin—lung cancer	0.00026	0.000717	CcSEcCtD
Dantrolene—Sweating—Methotrexate—lung cancer	0.000259	0.000715	CcSEcCtD
Dantrolene—Feeling abnormal—Cisplatin—lung cancer	0.000259	0.000714	CcSEcCtD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.000258	0.0023	CbGpPWpGaD
Dantrolene—Haematuria—Methotrexate—lung cancer	0.000258	0.000711	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000257	0.000709	CcSEcCtD
Dantrolene—Somnolence—Etoposide—lung cancer	0.000256	0.000706	CcSEcCtD
Dantrolene—Insomnia—Paclitaxel—lung cancer	0.000255	0.000704	CcSEcCtD
Dantrolene—Hypersensitivity—Irinotecan—lung cancer	0.000255	0.000703	CcSEcCtD
Dantrolene—Convulsion—Docetaxel—lung cancer	0.000254	0.0007	CcSEcCtD
Dantrolene—Hypertension—Docetaxel—lung cancer	0.000253	0.000698	CcSEcCtD
Dantrolene—Somnolence—Paclitaxel—lung cancer	0.000251	0.000692	CcSEcCtD
Dantrolene—Decreased appetite—Etoposide—lung cancer	0.00025	0.00069	CcSEcCtD
Dantrolene—Myalgia—Docetaxel—lung cancer	0.00025	0.000688	CcSEcCtD
Dantrolene—Nausea—Vinorelbine—lung cancer	0.000249	0.000687	CcSEcCtD
Dantrolene—Dyspepsia—Paclitaxel—lung cancer	0.000248	0.000685	CcSEcCtD
Dantrolene—Body temperature increased—Cisplatin—lung cancer	0.000248	0.000685	CcSEcCtD
Dantrolene—Asthenia—Irinotecan—lung cancer	0.000248	0.000685	CcSEcCtD
Dantrolene—Fatigue—Etoposide—lung cancer	0.000248	0.000684	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	0.000248	0.00221	CbGpPWpGaD
Dantrolene—Constipation—Etoposide—lung cancer	0.000246	0.000679	CcSEcCtD
Dantrolene—Pain—Etoposide—lung cancer	0.000246	0.000679	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000246	0.00219	CbGpPWpGaD
Dantrolene—Decreased appetite—Paclitaxel—lung cancer	0.000245	0.000676	CcSEcCtD
Dantrolene—Dry mouth—Docetaxel—lung cancer	0.000244	0.000673	CcSEcCtD
Dantrolene—Haemoglobin—Methotrexate—lung cancer	0.000244	0.000673	CcSEcCtD
Dantrolene—Fatigue—Paclitaxel—lung cancer	0.000243	0.000671	CcSEcCtD
Dantrolene—Haemorrhage—Methotrexate—lung cancer	0.000243	0.000669	CcSEcCtD
Dantrolene—Hepatitis—Methotrexate—lung cancer	0.000243	0.000669	CcSEcCtD
Dantrolene—Pollakiuria—Doxorubicin—lung cancer	0.000243	0.000669	CcSEcCtD
Dantrolene—Asthenia—Gemcitabine—lung cancer	0.000242	0.000667	CcSEcCtD
Dantrolene—Constipation—Paclitaxel—lung cancer	0.000241	0.000665	CcSEcCtD
Dantrolene—Pain—Paclitaxel—lung cancer	0.000241	0.000665	CcSEcCtD
Dantrolene—Confusional state—Docetaxel—lung cancer	0.000241	0.000665	CcSEcCtD
Dantrolene—Anaphylactic shock—Docetaxel—lung cancer	0.000239	0.00066	CcSEcCtD
Dantrolene—Pruritus—Gemcitabine—lung cancer	0.000239	0.000658	CcSEcCtD
Dantrolene—Feeling abnormal—Etoposide—lung cancer	0.000237	0.000654	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000237	0.00211	CbGpPWpGaD
Dantrolene—Diarrhoea—Irinotecan—lung cancer	0.000237	0.000653	CcSEcCtD
Dantrolene—Gastrointestinal pain—Etoposide—lung cancer	0.000235	0.000649	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000235	0.0021	CbGpPWpGaD
Dantrolene—Thrombocytopenia—Docetaxel—lung cancer	0.000234	0.000646	CcSEcCtD
Dantrolene—Drowsiness—Doxorubicin—lung cancer	0.000234	0.000645	CcSEcCtD
Dantrolene—Visual impairment—Methotrexate—lung cancer	0.000234	0.000645	CcSEcCtD
Dantrolene—Tachycardia—Docetaxel—lung cancer	0.000234	0.000644	CcSEcCtD
Dantrolene—Feeling abnormal—Paclitaxel—lung cancer	0.000233	0.000641	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000232	0.00207	CbGpPWpGaD
Dantrolene—Hypersensitivity—Cisplatin—lung cancer	0.000232	0.000638	CcSEcCtD
Dantrolene—Gastrointestinal pain—Paclitaxel—lung cancer	0.000231	0.000636	CcSEcCtD
Dantrolene—Diarrhoea—Gemcitabine—lung cancer	0.000231	0.000636	CcSEcCtD
Dantrolene—Renal failure—Doxorubicin—lung cancer	0.00023	0.000634	CcSEcCtD
Dantrolene—Dizziness—Irinotecan—lung cancer	0.000229	0.000631	CcSEcCtD
Dantrolene—Urticaria—Etoposide—lung cancer	0.000229	0.000631	CcSEcCtD
Dantrolene—Anorexia—Docetaxel—lung cancer	0.000228	0.000629	CcSEcCtD
Dantrolene—Abdominal pain—Etoposide—lung cancer	0.000228	0.000627	CcSEcCtD
Dantrolene—Body temperature increased—Etoposide—lung cancer	0.000228	0.000627	CcSEcCtD
Dantrolene—Asthenia—Cisplatin—lung cancer	0.000225	0.000622	CcSEcCtD
Dantrolene—Sweating—Doxorubicin—lung cancer	0.000224	0.000619	CcSEcCtD
Dantrolene—Urticaria—Paclitaxel—lung cancer	0.000224	0.000618	CcSEcCtD
Dantrolene—Haematuria—Doxorubicin—lung cancer	0.000223	0.000615	CcSEcCtD
Dantrolene—Abdominal pain—Paclitaxel—lung cancer	0.000223	0.000615	CcSEcCtD
Dantrolene—Body temperature increased—Paclitaxel—lung cancer	0.000223	0.000615	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—ALB—lung cancer	0.000222	0.00198	CbGpPWpGaD
Dantrolene—Vomiting—Irinotecan—lung cancer	0.00022	0.000607	CcSEcCtD
Dantrolene—Rash—Irinotecan—lung cancer	0.000218	0.000602	CcSEcCtD
Dantrolene—Dermatitis—Irinotecan—lung cancer	0.000218	0.000601	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000218	0.000601	CcSEcCtD
Dantrolene—Chills—Methotrexate—lung cancer	0.000218	0.0006	CcSEcCtD
Dantrolene—Headache—Irinotecan—lung cancer	0.000217	0.000598	CcSEcCtD
Dantrolene—Insomnia—Docetaxel—lung cancer	0.000216	0.000597	CcSEcCtD
Dantrolene—Diarrhoea—Cisplatin—lung cancer	0.000215	0.000593	CcSEcCtD
Dantrolene—Vomiting—Gemcitabine—lung cancer	0.000214	0.000591	CcSEcCtD
Dantrolene—Somnolence—Docetaxel—lung cancer	0.000213	0.000586	CcSEcCtD
Dantrolene—Rash—Gemcitabine—lung cancer	0.000213	0.000586	CcSEcCtD
Dantrolene—Dermatitis—Gemcitabine—lung cancer	0.000212	0.000585	CcSEcCtD
Dantrolene—Hypersensitivity—Etoposide—lung cancer	0.000212	0.000585	CcSEcCtD
Dantrolene—Erythema—Methotrexate—lung cancer	0.000211	0.000582	CcSEcCtD
Dantrolene—Haemoglobin—Doxorubicin—lung cancer	0.000211	0.000582	CcSEcCtD
Dantrolene—Headache—Gemcitabine—lung cancer	0.000211	0.000582	CcSEcCtD
Dantrolene—Dyspepsia—Docetaxel—lung cancer	0.000211	0.000581	CcSEcCtD
Dantrolene—Hepatitis—Doxorubicin—lung cancer	0.00021	0.000579	CcSEcCtD
Dantrolene—Haemorrhage—Doxorubicin—lung cancer	0.00021	0.000579	CcSEcCtD
Dantrolene—Decreased appetite—Docetaxel—lung cancer	0.000208	0.000573	CcSEcCtD
Dantrolene—Hypersensitivity—Paclitaxel—lung cancer	0.000208	0.000573	CcSEcCtD
Dantrolene—Dysgeusia—Methotrexate—lung cancer	0.000207	0.00057	CcSEcCtD
Dantrolene—Asthenia—Etoposide—lung cancer	0.000207	0.000569	CcSEcCtD
Dantrolene—Fatigue—Docetaxel—lung cancer	0.000206	0.000569	CcSEcCtD
Dantrolene—Nausea—Irinotecan—lung cancer	0.000206	0.000567	CcSEcCtD
Dantrolene—Constipation—Docetaxel—lung cancer	0.000205	0.000564	CcSEcCtD
Dantrolene—Pain—Docetaxel—lung cancer	0.000205	0.000564	CcSEcCtD
Dantrolene—Back pain—Methotrexate—lung cancer	0.000204	0.000563	CcSEcCtD
Dantrolene—Pruritus—Etoposide—lung cancer	0.000204	0.000562	CcSEcCtD
Dantrolene—Visual impairment—Doxorubicin—lung cancer	0.000203	0.000558	CcSEcCtD
Dantrolene—Asthenia—Paclitaxel—lung cancer	0.000203	0.000558	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—RAF1—lung cancer	0.000201	0.00179	CbGpPWpGaD
Dantrolene—Nausea—Gemcitabine—lung cancer	0.0002	0.000552	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.0002	0.00178	CbGpPWpGaD
Dantrolene—Vomiting—Cisplatin—lung cancer	0.0002	0.000551	CcSEcCtD
Dantrolene—Pruritus—Paclitaxel—lung cancer	0.0002	0.000551	CcSEcCtD
Dantrolene—Vision blurred—Methotrexate—lung cancer	0.000199	0.000549	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—CAT—lung cancer	0.000199	0.00177	CbGpPWpGaD
Dantrolene—Rash—Cisplatin—lung cancer	0.000198	0.000546	CcSEcCtD
Dantrolene—Dermatitis—Cisplatin—lung cancer	0.000198	0.000546	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000198	0.00176	CbGpPWpGaD
Dantrolene—Feeling abnormal—Docetaxel—lung cancer	0.000197	0.000544	CcSEcCtD
Dantrolene—Diarrhoea—Etoposide—lung cancer	0.000197	0.000543	CcSEcCtD
Dantrolene—Ill-defined disorder—Methotrexate—lung cancer	0.000196	0.00054	CcSEcCtD
Dantrolene—Gastrointestinal pain—Docetaxel—lung cancer	0.000196	0.000539	CcSEcCtD
Dantrolene—Anaemia—Methotrexate—lung cancer	0.000195	0.000538	CcSEcCtD
Dantrolene—Flushing—Doxorubicin—lung cancer	0.000195	0.000538	CcSEcCtD
Dantrolene—Diarrhoea—Paclitaxel—lung cancer	0.000193	0.000532	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—CNDP2—lung cancer	0.000193	0.00172	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTM2—lung cancer	0.000193	0.00172	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000191	0.0017	CbGpPWpGaD
Dantrolene—Malaise—Methotrexate—lung cancer	0.000191	0.000525	CcSEcCtD
Dantrolene—Dizziness—Etoposide—lung cancer	0.00019	0.000525	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	0.00019	0.0017	CbGpPWpGaD
Dantrolene—Abdominal pain—Docetaxel—lung cancer	0.000189	0.000521	CcSEcCtD
Dantrolene—Body temperature increased—Docetaxel—lung cancer	0.000189	0.000521	CcSEcCtD
Dantrolene—Leukopenia—Methotrexate—lung cancer	0.000189	0.000521	CcSEcCtD
Dantrolene—Chills—Doxorubicin—lung cancer	0.000189	0.00052	CcSEcCtD
Dantrolene—Dizziness—Paclitaxel—lung cancer	0.000187	0.000515	CcSEcCtD
Dantrolene—Nausea—Cisplatin—lung cancer	0.000187	0.000515	CcSEcCtD
Dantrolene—Convulsion—Methotrexate—lung cancer	0.000183	0.000505	CcSEcCtD
Dantrolene—Vomiting—Etoposide—lung cancer	0.000183	0.000505	CcSEcCtD
Dantrolene—Erythema—Doxorubicin—lung cancer	0.000183	0.000504	CcSEcCtD
Dantrolene—Rash—Etoposide—lung cancer	0.000182	0.0005	CcSEcCtD
Dantrolene—Dermatitis—Etoposide—lung cancer	0.000181	0.0005	CcSEcCtD
Dantrolene—Headache—Etoposide—lung cancer	0.00018	0.000497	CcSEcCtD
Dantrolene—Myalgia—Methotrexate—lung cancer	0.00018	0.000496	CcSEcCtD
Dantrolene—Tension—Doxorubicin—lung cancer	0.00018	0.000495	CcSEcCtD
Dantrolene—Vomiting—Paclitaxel—lung cancer	0.000179	0.000495	CcSEcCtD
Dantrolene—Dysgeusia—Doxorubicin—lung cancer	0.000179	0.000494	CcSEcCtD
Dantrolene—Rash—Paclitaxel—lung cancer	0.000178	0.000491	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	0.000178	0.00158	CbGpPWpGaD
Dantrolene—Dermatitis—Paclitaxel—lung cancer	0.000178	0.00049	CcSEcCtD
Dantrolene—Discomfort—Methotrexate—lung cancer	0.000178	0.00049	CcSEcCtD
Dantrolene—Nervousness—Doxorubicin—lung cancer	0.000178	0.00049	CcSEcCtD
Dantrolene—Back pain—Doxorubicin—lung cancer	0.000177	0.000488	CcSEcCtD
Dantrolene—Headache—Paclitaxel—lung cancer	0.000177	0.000488	CcSEcCtD
Dantrolene—Hypersensitivity—Docetaxel—lung cancer	0.000176	0.000486	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—CYP2A7—lung cancer	0.000175	0.00155	CbGpPWpGaD
Dantrolene—Confusional state—Methotrexate—lung cancer	0.000174	0.000479	CcSEcCtD
Dantrolene—Anaphylactic shock—Methotrexate—lung cancer	0.000172	0.000475	CcSEcCtD
Dantrolene—Vision blurred—Doxorubicin—lung cancer	0.000172	0.000475	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	0.000172	0.00153	CbGpPWpGaD
Dantrolene—Asthenia—Docetaxel—lung cancer	0.000172	0.000473	CcSEcCtD
Dantrolene—Nausea—Etoposide—lung cancer	0.000171	0.000471	CcSEcCtD
Dantrolene—Ill-defined disorder—Doxorubicin—lung cancer	0.00017	0.000468	CcSEcCtD
Dantrolene—Pruritus—Docetaxel—lung cancer	0.000169	0.000467	CcSEcCtD
Dantrolene—Anaemia—Doxorubicin—lung cancer	0.000169	0.000466	CcSEcCtD
Dantrolene—Thrombocytopenia—Methotrexate—lung cancer	0.000169	0.000465	CcSEcCtD
Dantrolene—Nausea—Paclitaxel—lung cancer	0.000168	0.000462	CcSEcCtD
Dantrolene—Hyperhidrosis—Methotrexate—lung cancer	0.000167	0.00046	CcSEcCtD
Dantrolene—Malaise—Doxorubicin—lung cancer	0.000165	0.000455	CcSEcCtD
Dantrolene—Anorexia—Methotrexate—lung cancer	0.000164	0.000453	CcSEcCtD
Dantrolene—Leukopenia—Doxorubicin—lung cancer	0.000164	0.000451	CcSEcCtD
Dantrolene—Diarrhoea—Docetaxel—lung cancer	0.000164	0.000451	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000162	0.00145	CbGpPWpGaD
Dantrolene—Convulsion—Doxorubicin—lung cancer	0.000159	0.000437	CcSEcCtD
Dantrolene—Dizziness—Docetaxel—lung cancer	0.000158	0.000436	CcSEcCtD
Dantrolene—Hypertension—Doxorubicin—lung cancer	0.000158	0.000435	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000157	0.000433	CcSEcCtD
Dantrolene—Insomnia—Methotrexate—lung cancer	0.000156	0.00043	CcSEcCtD
Dantrolene—Myalgia—Doxorubicin—lung cancer	0.000156	0.000429	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000156	0.00139	CbGpPWpGaD
Dantrolene—Discomfort—Doxorubicin—lung cancer	0.000154	0.000424	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.000153	0.00137	CbGpPWpGaD
Dantrolene—Somnolence—Methotrexate—lung cancer	0.000153	0.000423	CcSEcCtD
Dantrolene—Dry mouth—Doxorubicin—lung cancer	0.000152	0.00042	CcSEcCtD
Dantrolene—Vomiting—Docetaxel—lung cancer	0.000152	0.000419	CcSEcCtD
Dantrolene—Dyspepsia—Methotrexate—lung cancer	0.000152	0.000418	CcSEcCtD
Dantrolene—Rash—Docetaxel—lung cancer	0.000151	0.000416	CcSEcCtD
Dantrolene—Dermatitis—Docetaxel—lung cancer	0.000151	0.000416	CcSEcCtD
Dantrolene—Confusional state—Doxorubicin—lung cancer	0.000151	0.000415	CcSEcCtD
Dantrolene—Decreased appetite—Methotrexate—lung cancer	0.00015	0.000413	CcSEcCtD
Dantrolene—Headache—Docetaxel—lung cancer	0.00015	0.000413	CcSEcCtD
Dantrolene—Anaphylactic shock—Doxorubicin—lung cancer	0.000149	0.000412	CcSEcCtD
Dantrolene—Fatigue—Methotrexate—lung cancer	0.000149	0.00041	CcSEcCtD
Dantrolene—Pain—Methotrexate—lung cancer	0.000147	0.000407	CcSEcCtD
Dantrolene—Thrombocytopenia—Doxorubicin—lung cancer	0.000146	0.000403	CcSEcCtD
Dantrolene—Tachycardia—Doxorubicin—lung cancer	0.000146	0.000402	CcSEcCtD
Dantrolene—Hyperhidrosis—Doxorubicin—lung cancer	0.000144	0.000398	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000144	0.00128	CbGpPWpGaD
Dantrolene—Anorexia—Doxorubicin—lung cancer	0.000142	0.000392	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.000142	0.00127	CbGpPWpGaD
Dantrolene—Nausea—Docetaxel—lung cancer	0.000142	0.000392	CcSEcCtD
Dantrolene—Feeling abnormal—Methotrexate—lung cancer	0.000142	0.000392	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000142	0.00126	CbGpPWpGaD
Dantrolene—Gastrointestinal pain—Methotrexate—lung cancer	0.000141	0.000389	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.00014	0.00125	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.000139	0.00123	CbGpPWpGaD
Dantrolene—Urticaria—Methotrexate—lung cancer	0.000137	0.000378	CcSEcCtD
Dantrolene—Body temperature increased—Methotrexate—lung cancer	0.000136	0.000376	CcSEcCtD
Dantrolene—Abdominal pain—Methotrexate—lung cancer	0.000136	0.000376	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000136	0.000375	CcSEcCtD
Dantrolene—Insomnia—Doxorubicin—lung cancer	0.000135	0.000372	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000134	0.00119	CbGpPWpGaD
Dantrolene—Somnolence—Doxorubicin—lung cancer	0.000133	0.000366	CcSEcCtD
Dantrolene—Dyspepsia—Doxorubicin—lung cancer	0.000131	0.000362	CcSEcCtD
Dantrolene—Decreased appetite—Doxorubicin—lung cancer	0.00013	0.000358	CcSEcCtD
Dantrolene—Fatigue—Doxorubicin—lung cancer	0.000129	0.000355	CcSEcCtD
Dantrolene—Constipation—Doxorubicin—lung cancer	0.000128	0.000352	CcSEcCtD
Dantrolene—Pain—Doxorubicin—lung cancer	0.000128	0.000352	CcSEcCtD
Dantrolene—Hypersensitivity—Methotrexate—lung cancer	0.000127	0.00035	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000126	0.00113	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.000124	0.00111	CbGpPWpGaD
Dantrolene—Asthenia—Methotrexate—lung cancer	0.000124	0.000341	CcSEcCtD
Dantrolene—Feeling abnormal—Doxorubicin—lung cancer	0.000123	0.000339	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.000123	0.00109	CbGpPWpGaD
Dantrolene—Gastrointestinal pain—Doxorubicin—lung cancer	0.000122	0.000337	CcSEcCtD
Dantrolene—Pruritus—Methotrexate—lung cancer	0.000122	0.000336	CcSEcCtD
Dantrolene—Urticaria—Doxorubicin—lung cancer	0.000119	0.000327	CcSEcCtD
Dantrolene—Abdominal pain—Doxorubicin—lung cancer	0.000118	0.000325	CcSEcCtD
Dantrolene—Body temperature increased—Doxorubicin—lung cancer	0.000118	0.000325	CcSEcCtD
Dantrolene—Diarrhoea—Methotrexate—lung cancer	0.000118	0.000325	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000117	0.00104	CbGpPWpGaD
Dantrolene—Dizziness—Methotrexate—lung cancer	0.000114	0.000314	CcSEcCtD
Dantrolene—Hypersensitivity—Doxorubicin—lung cancer	0.00011	0.000303	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	0.00011	0.000977	CbGpPWpGaD
Dantrolene—Vomiting—Methotrexate—lung cancer	0.00011	0.000302	CcSEcCtD
Dantrolene—Rash—Methotrexate—lung cancer	0.000109	0.0003	CcSEcCtD
Dantrolene—Dermatitis—Methotrexate—lung cancer	0.000109	0.000299	CcSEcCtD
Dantrolene—Headache—Methotrexate—lung cancer	0.000108	0.000298	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000107	0.000955	CbGpPWpGaD
Dantrolene—Asthenia—Doxorubicin—lung cancer	0.000107	0.000295	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—HPGDS—lung cancer	0.000106	0.000942	CbGpPWpGaD
Dantrolene—Pruritus—Doxorubicin—lung cancer	0.000106	0.000291	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—GSTT1—lung cancer	0.000103	0.000913	CbGpPWpGaD
Dantrolene—Nausea—Methotrexate—lung cancer	0.000102	0.000282	CcSEcCtD
Dantrolene—Diarrhoea—Doxorubicin—lung cancer	0.000102	0.000282	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—GCLC—lung cancer	0.000101	0.000903	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP2A6—lung cancer	0.000101	0.000903	CbGpPWpGaD
Dantrolene—Dizziness—Doxorubicin—lung cancer	9.87e-05	0.000272	CcSEcCtD
Dantrolene—Vomiting—Doxorubicin—lung cancer	9.49e-05	0.000262	CcSEcCtD
Dantrolene—Rash—Doxorubicin—lung cancer	9.42e-05	0.00026	CcSEcCtD
Dantrolene—Dermatitis—Doxorubicin—lung cancer	9.41e-05	0.000259	CcSEcCtD
Dantrolene—Headache—Doxorubicin—lung cancer	9.35e-05	0.000258	CcSEcCtD
Dantrolene—Nausea—Doxorubicin—lung cancer	8.87e-05	0.000245	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	8.69e-05	0.000774	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP2E1—lung cancer	8.62e-05	0.000768	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	8.5e-05	0.000757	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTP1—lung cancer	7.11e-05	0.000633	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	7.01e-05	0.000624	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTM1—lung cancer	6.53e-05	0.000582	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	6.44e-05	0.000574	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP1A1—lung cancer	6.19e-05	0.000552	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	6.11e-05	0.000544	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—COL4A3BP—lung cancer	5.45e-05	0.000485	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AZIN2—lung cancer	5.45e-05	0.000485	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ATP5H—lung cancer	4.63e-05	0.000413	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—POMC—lung cancer	4.62e-05	0.000411	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLBD1—lung cancer	4.13e-05	0.000368	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HSD17B10—lung cancer	3.78e-05	0.000336	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CKB—lung cancer	3.51e-05	0.000313	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTM2—lung cancer	3.3e-05	0.000294	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CNDP2—lung cancer	3.3e-05	0.000294	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MTMR3—lung cancer	3.21e-05	0.000286	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PGAM1—lung cancer	3.13e-05	0.000279	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP2A7—lung cancer	2.98e-05	0.000266	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SDC4—lung cancer	2.92e-05	0.00026	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTA3—lung cancer	2.66e-05	0.000237	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—RRM1—lung cancer	2.66e-05	0.000237	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—B4GALT5—lung cancer	2.5e-05	0.000223	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTA4—lung cancer	2.43e-05	0.000217	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTA2—lung cancer	2.37e-05	0.000211	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTA1—lung cancer	2.29e-05	0.000204	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ABCC3—lung cancer	2.26e-05	0.000201	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AKR1C1—lung cancer	2.19e-05	0.000195	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—UGT1A1—lung cancer	2.13e-05	0.000189	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GNG11—lung cancer	2.05e-05	0.000183	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALDOA—lung cancer	1.95e-05	0.000174	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NCOA3—lung cancer	1.9e-05	0.000169	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ADCY1—lung cancer	1.84e-05	0.000164	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ABCG2—lung cancer	1.84e-05	0.000164	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ENO2—lung cancer	1.81e-05	0.000161	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HPGDS—lung cancer	1.81e-05	0.000161	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.8e-05	0.00016	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTT1—lung cancer	1.75e-05	0.000156	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GCLC—lung cancer	1.73e-05	0.000154	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP2A6—lung cancer	1.73e-05	0.000154	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ENO1—lung cancer	1.64e-05	0.000146	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP2E1—lung cancer	1.47e-05	0.000131	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NQO1—lung cancer	1.46e-05	0.00013	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—STK11—lung cancer	1.31e-05	0.000117	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTP1—lung cancer	1.22e-05	0.000108	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CAT—lung cancer	1.18e-05	0.000105	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ABCB1—lung cancer	1.15e-05	0.000102	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—TYMS—lung cancer	1.13e-05	0.000101	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTM1—lung cancer	1.12e-05	9.95e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP1A1—lung cancer	1.06e-05	9.43e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ERCC2—lung cancer	1.05e-05	9.36e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOA1—lung cancer	9.09e-06	8.09e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3CG—lung cancer	8.3e-06	7.39e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—POMC—lung cancer	7.9e-06	7.03e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CREBBP—lung cancer	7.69e-06	6.85e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3CD—lung cancer	7.29e-06	6.5e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALB—lung cancer	7.2e-06	6.41e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3CB—lung cancer	6.36e-06	5.66e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTGS2—lung cancer	6.3e-06	5.61e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTEN—lung cancer	5.49e-06	4.89e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—EP300—lung cancer	5.24e-06	4.67e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3CA—lung cancer	3.87e-06	3.45e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AKT1—lung cancer	3.17e-06	2.82e-05	CbGpPWpGaD
